[M(CO)2(NO)], a new core in bioorganometallic chemistry: model complexes of [Re(CO)2(NO)] and [Tc(CO)2(NO)]

In this study selected bidentate (L²) and tridentate (L³) ligands were coordinated to the Re(I) or Tc(I) core [M(CO)₂(NO)]²⁺ resulting in complexes of the general formula fac-[MX(L²)(CO)₂(NO)] and fac-[M(L³)(CO)₂(NO)] (M = Re or Tc; X = Br or Cl). The complexes were obtained directly from the reaction of [M(CO)₂(NO)]²⁺ with the ligand or indirectly by first reacting the ligand with [M(CO)₃]⁺ and subsequent nitrosylation with [NO][BF₄] or [NO][HSO₄]. Most of the reactions were performed with cold rhenium on a macroscopic level before the conditions were adapted to the n.c.a. level with technetium (^99mTc). Chloride, bromide and nitrate were used as monodentate ligands, picolinic acid (PIC) as a bidentate ligand and histidine (HIS), iminodiacetic acid (IDA) and nitrilotriacetic acid (NTA) as tridentate ligands. We synthesised and describe the dinuclear complex [ReCl(μ-Cl)(CO)₂(NO)]₂ and the mononuclear complexes [NEt₄][ReCl₃(CO)₂(NO)], [NEt₄][ReBr₃(CO)₂(NO)], [ReBr(PIC)(CO)₂(NO)], [NMe₄][Re(NO₃)₃(CO)₂(NO)], [Re(HIS)(CO)₂(NO)][BF₄], [⁹⁹Tc(HIS)(CO)₂(NO)][BF₄], [^99mTc(IDA)(CO)₂ (NO)] and [^99mTc(NTA)(CO)₂(NO)]. The chemical and physical characteristics of the Re and Tc-dicarbonyl-nitrosyl complexes differ significantly from those of the corresponding tricarbonyl compounds.     

Comparative electrochemistry of technetium(V) and rhenium(V) dioxo complexes

The heavy use of^99mTc in nuclear medicine and the recent development of¹⁸⁸Re radiopharmaceuticals have encouraged the comparative study of Tc and Re coordination compounds. In this work, the electrochemistry of [M^VO₂ (amine)₂]⁺ (M=Tc, Re; amine = ethylenediamine, 1,3-diaminopropane, diethylenetriamine, triethylenetetramine) complexes is studied by cyclic voltammetry and the results are compared. The voltammograms of these compounds, obtained at different pH values, show that [ReO₂(amine)₂]⁺ cations are thermodynamically stable even when protonated. On the other hand, analogous Tc compounds are not so stable and easily decompose if existing as [TcO(OH) (amine)₂]²⁺.     

Exploring the nitrosyl-approach: “Re(CO)2(NO)”- and “Tc(CO)2(NO)”-complexes provide new pathways for bioorganometallic chemistry

Nitrosylation reactions are rare in the context of low valent Re(I)- and Tc(I)-tricarbonyl complexes so far. We herein describe a method for the conversion of a “M(CO)₃-moiety” (M = Re, Tc) into a dicarbonyl-nitrosyl moiety “M(CO)₂NO”, the synthesis of important precursor complexes and intermediates and possible applications for this new kind of Re- and Tc-chemistry.The behavior of the complex [ReCl₃(CO)₂(NO)]⁻ in water was studied in detail and compared to that of [ReCl₃(CO)₃]²⁻. Contrary to the conversion of [ReCl₃(CO)₃]²⁻ to the mixed aquo-carbonyl complex [Re(OH₂)₃(CO)₃]⁺ in water, one chloride remains initially bound to the metal center in the dicarbonyl-nitrosyl complex, making [ReCl(OH₂)₂(CO)₂(NO)]⁺ the main species for further reactions. In this context, we isolated and characterized the complex [Re(μ₃-O)(CO)₂(NO)]₄. Examples of complexes with different bi- and tridentate ligands based on ReCl₃(CO)₂(NO)]⁻ are discussed.For the development of potential new radiopharmaceuticals we also adapted the nitrosylation technique to the n.c.a. level with ^99mTc. [^99mTc(OH₂)₃(CO)₃]⁺ served as starting material to form a ^99mTc(CO)₂(NO)-core. Labelling reactions with ligands such as iminodiacetic acid (IDA), nitrilotriacetic acid (NTA) and diethylenetriamine pentaacetic acid (DTPA) were performed, resulting in the complexes [^99mTc(IDA)(CO)₂(NO)], [^99mTc(NTA)(CO)₂(NO)] and [^99mTc(DTPA)(CO)₂(NO)]. In this way, the “nitrosyl-approach” adds a new and challenging synthetic tool to the already established organometallic chemistry of Re- and Tc-tricarbonyl complexes.     

Synthesis and characterization of organometallic rhenium(І) and technetium(І) bile acid complexes

Eight bile acid derivatives have been synthesized with alkyl chains of various length based tridentate ligand chelating system. These derivatives have been reacted with the precursor [Et₄N]₂[Re(CO)₃Br₃] and fac-[M(CO)₃(H₂O)₃]⁺ (M = ^99mTc, Re) in ethanol or ethanol–aqueous media to form water-soluble and stable organometallic complexes in good yields. ¹H NMR, ¹³C NMR, IR and elemental analysis or HRMS spectroscopic analyses confirmed the tridentate complexation of the metal–tricarbonyl fragment exclusively via the tridentate chelates. In addition, the corresponding radioactive technetium-99m complexes were prepared successfully and challenged for stability in physiological phosphate buffer at 37 °C for 24 h. No decomposition of the complexes could be detected under the condition proving the stability of these complexes.     

A ‘preformed chelate approach’ model for coupling amine-modified rhenium and technetium ‘3+1’ mixed ligand complexes to carboxylate residues: Crystal structure of ReO[CH3SCH2CH2N(CH2CH2S)2][p-SC6H4NH2] and ReO[CH3SCH2CH2N(CH2CH2S)2][p-SC6H4NHCOC6H5]

Selected ‘3+1’ mixed ligand oxorhenium and oxotechnetium complexes containing the SNS/S donor atom set have been modified by introduction of a bifunctional amine anchor on the p-position of the thiophenolato monodentate ligand. A representative series of complexes containing several tridentate ligands was prepared both at macromolar (Re complexes) and nanomolar (^99mTc complexes) amounts. Coupling of these complexes to activated carboxylate groups was performed according to the ‘preformed chelate approach’ using benzoyl chloride as a model molecule. Coupling yields were high both at nanomolar and millimolar metal concentration, as revealed by high-performance liquid chromatographic analysis of ^99mTc and Re species adopting parallel radiometric and photometric detection modes. All Re compounds have been characterized by classical analytical methods. In addition, the structures of representative parent ReO[CH₃SCH₂CH₂N(CH₂CH₂S)₂][p-SC₆H₄NH₂] and daughter ReO[CH₃SCH₂CH₂N(CH₂CH₂S)₂][p-SC₆H₄NHCOC₆H₅] complexes were solved by X-ray crystallography. Both compounds adopt a distorted trigonal bipyramidal geometry around rhenium, wherein the oxo group and the sulfur atoms of the SNS ligand occupy the equatorial plane and the nitrogen atom and the sulfur of the monothiol are located at the apical positions trans to each other.     

Synthesis, in vitro and in silico assessment of organometallic Rhenium(I) and Technetium(I) thymidine complexes

Thymidine kinases have been identified as suitable targets for non-invasive imaging of gene therapy and cancer. Thus, there is a high interest in new, reliable and inexpensive radiolabeled thymidine analogues for these applications. In this study we present the synthesis and in vitro evaluation of M(CO)₃-complexes of thymidine (M = ^99mTc, Re) for potential use in SPECT tumor imaging. 5′-amino-5′-deoxythymidine was derivatized at position C5′ with spacers of various lengths (∼0-30 Å) carrying tridentate metal chelating entities such as iminodiacetic acid and picolylamine-N-monoacetic acid. The nucleoside derivatives were reacted with the precursors [ReBr₃(CO)₃]²⁻ and [^99mTc(OH₂)₃(CO)₃]⁺, respectively. The organometallic thymidine complexes have been fully characterized by means of IR, NMR and mass spectrometry. Enzyme kinetic studies revealed mixed inhibition of the human cytosolic thymidine kinase with K_i values ranging from 4.4 to 334 μM for all thymidine complexes. Competitive inhibition of herpes simplex virus type 1 thymidine kinase was only achieved when thymidine and the metal core were separated by a spacer of approximately 30 Å length. These findings were supported by in silico molecular docking and molecular dynamic experiments.     

Organometallic Tc-technetium(I)- and Re-rhenium(I)-folate derivatives for potential use in nuclear medicine

The folate receptor (FR) is a high affinity membrane protein which is overexpressed on a wide variety of tumor cells, but highly restricted in normal tissues. Therefore folate derivatives labeled with short living isotopes such as ^99mTc (γ, t_1/2 = 6 h) or ¹⁸⁸Re (β⁻, t_1/2 = 17 h) could be used for tumor diagnosis and therapy. In this respect there is a great interest to develop organometallic technetium(I) and rhenium(I) modified folate radiopharmaceuticals. For this purpose folic acid was functionalized with a tridentate picolylamine monoacetic acid chelating system. The chelating system was selectively coupled via an aminohexane spacer to the γ- or α-carboxyl group of the glutamate moiety of folic acid to obtain the corresponding γ- or α-folate derivative or - if directly attached to pteroic acid - the pteroate derivative. The derivatives were reacted with the precursor [M(OH₂)₃(CO)₃]⁺ (M = ^99mTc, Re) to form uniform organometallic folate complexes under mild reaction conditions. All compounds were chemically characterized by means of NMR, MS, IR and HPLC. The determination of the IC₅₀-values for the PAMA-γ-folate derivative (100 nM) and the corresponding organometallic rhenium complex (110 nM) proved retained receptor binding properties. The radiolabeling with [^99mTc(OH₂)₃(CO)₃]⁺ was achieved in excellent yield (>95%) at low ligand concentration (10⁻⁴ M). The cell binding (>45% of total activity) and internalization (>15% of total activity) of all ^99mTc-complexes was very high and specificity for the FR was proved by their complete displacement with excess folic acid. The ^99mTc-complexes were positively tested for their plasma stability and for the absence of binding to plasma proteins.     

S‐Functionalized Cysteine: Powerful Ligands for the Labelling of Bioactive Molecules with Triaquatricarbonyltechnetium‐99m(1+) ([99mTc(OH2)3(CO)3]+)

S‐Alkylated cysteines are used as efficient tridentate N,O,S‐donor‐atom ligands for the fac‐[M(CO)₃]⁺ moiety (M=^99mTc or Re). Reaction of (Et₄N)₂[ReBr₃(CO)₃] ( 3 ) with the model S‐benzyl‐L ‐cysteine ( 2 ) leads to the formation of [Re( 2′ )(CO)₃] ( 4 ) as the exclusive product ( 2′ =C‐terminal anion of 2 ). The tridentate nature of the alkylated cysteine in 4 was established by X‐ray crystallography. Compound 2 reacts with [^99mTc(OH₂)₃(CO)₃]⁺ under mild conditions (10⁻⁴ M , 50°, 30 min) to afford [^99mTc( 2′ )(CO)₃] ( 5 ) and represents, therefore, an efficient chelator for the labelling of biomolecules. L ‐Cysteine, S‐alkylated with a 3‐aminopropyl group (→ 7 ), was conjugated via a peptide coupling sequence with Coα‐[α‐(5,6‐dimethyl‐1H‐benzimidazolyl)]‐Coβ‐cyanocobamic b‐acid ( 6 ), the b‐acid of cyanocob(III)alamin (vitamin B₁₂) (Scheme 3). More convenient was a one‐pot procedure with a derivative of vitamin B₁₂ comprising a free amine group at the b‐position. This amine 15 was treated with NHS (N‐hydroxysuccinimide)‐activated 1‐iodoacetic acid 14 to introduce an I‐substituent in vitamin B₁₂. Subsequent addition of unprotected L ‐cysteine resulted in nucleophilic displacement of the I‐atom by the S‐substituent, affording the vitamin B₁₂ alkylated cysteine fragment 17 (Scheme 4). The procedure was quantitative and did not require purification of intermediates. Both cobalamin–cysteine conjugates could be efficiently labelled with [^99mTc(OH₂)₃(CO)₃]⁺ ( 1 ) under conditions identical to those of the model complex 5 . Biodistribution studies of the cobalamin conjugates in mice bearing B10‐F16 melanoma tumors showed a tumor uptake of 8.1±0.6% and 4.4±0.5% injected dose per gram of tumor tissue after 4 h and 24 h, respectively (Table 1).     

Imidazole-based bifunctional chelates for the “fac-[Re(CO)3]” core

Three monocationic rhenium(I) complexes of the type [Re(CO)₃(L)]Br, containing the bis-imidazole tridentate ligands bis-(2-(1-methylimidazolyl)methyl)amine (L¹), bis-(2-(1-methylimidazolyl)methyl)aminoethanol (L²) and bis-(2-(benzimidazolyl)ethyl)sulfide (L³), were prepared and characterized by ¹H NMR and IR spectroscopy. The complex salt [Re(CO)₃(L²)]Br (2) was also characterized by X-ray crystallography. The structure consists of discrete monocationic monomers with a fac-[Re(CO)₃]⁺ coordination unit, and the remaining three sites are occupied by one amine and two imidazolyl nitrogen donor atoms.     

Synthesis and biodistribution of two novel 99mTc “3+1”mixed ligand complexes as potential brain perfusion agents

The research in the last decade has been mainly aimed at the development of technetium-99m radiopharmaceuticals, among which are the “3+1”mixed ligand complexes. Two novel [^99mTc]“3+1”mixed ligand complexes each carrying the tridentate ligand, the N-(o-Methylthiophenyl)ethylenediamine or the N-(o-Methylthiophenyl)-b-mercaptoacetamide in combination with monothiolate coligand were produced using stannous chloride as reductant and glucoheptonate as transfer ligand. The identification of [^99mTc]-6 and [^99mTc]-7 was established by thin layer chromatography. The radiochemical purity of two complexes was over 90%. Biodistribution data in mice showed that both [^99mTc]-6 and [^99mTc]-7 can penetrate the intact blood-brain barrier and exhibited retention in mice brain. The brain uptakes (%ID/g) were 1.76, 1.17, 0.90 and 0.68, 0.38 ,0.37 at 2, 30, and 60 minutes i.v. postinjection for [^99mTc]-6 and [^99mTc]-7, respectively. Examples in this report comfirm us that it is promising to develop ^99mTc complexes as potential brain perfusion agents based on modifying either the tridentate or the monodentate ligands. This revised version was published online in August 2006 with corrections to the Cover Date.     

Cyclopentadienyl tricarbonyl complexes of Tc for the in vivo imaging of the serotonin 5-HT1A receptor in the brain

Technetium and rhenium tricarbonyl complexes with derivatized cyclopentadienyl ligands were prepared starting from pertechnetate and an appropriate ferrocene ligand. Furthermore, the complexes (M(CO)₃cp-COOC₅H₉N-R, M = Tc, Re; R = Me, isopropyl) could be obtained starting from the precursor complexes [^99mTc(CO)₃(H₂O)₃]⁺ and [Re(CO)₃Br₃]²⁻. Their chemical identity was confirmed by chromatographic methods and electron spray mass spectrometry. The biodistribution of the ^99mTc complexes (cytectrene I and cytectrene II) in Wistar rats was studied. Both compounds show high uptake in the brain and fast blood clearance. The pattern of regional distribution in the brain demonstrated in autoradiographic studies indicates binding to the 5-HT_1A and α₁ adrenergic receptors.     

Rhenium(I) and technetium(I) fac-M(NSO)(CO)3 (M = Re,Tc) tricarbonyl complexes,with a tridentate NSO bifunctional agent: Synthesis,structural characterization,and radiochemistry

The synthesis and structural characterization of the neutral rhenium complex fac-[Re(NSO)(CO)₃], Re-1, where (NSO) is a tridentate bifunctional chelating agent, 3-(carboxymethylthio)-3-(1H-imidazol-4-yl)propanoic acid (1), is presented. The complex crystallized from methanol–water and its structure was assigned by IR and ¹H, ¹³C NMR spectroscopies and X-ray crystallography. Furthermore, the analogous technetium complex fac-[^99mTc(NSO)(CO)₃], ^99mTc-1, was synthesized in high yield by reacting ligand 1 with the fac-[^99mTc(OH₂)₃(CO)₃]⁺ precursor for 30 min at 85 °C. The tracer complex was found to be more than 95% stable in the L-histidine challenge experiment. Our data indicate that the bifunctional NSO chelating agent 1 can be successfully applied for the development of potential ^99mTc-radiopharmaceuticals.     

Pyridine-tert-nitrogen-phenol ligands: N,N,O-Type tripodal chelates for the [M(CO)3]+ core (M = Re, Tc)

The design rationale, synthesis, and preliminary radiolabeling evaluation of new N,N,O-type pyridyl- tert-nitrogen-phenol ligands for the [M(CO) 3] (+) core, where M = (99m)Tc or Re, are described. The capability of the ligands to bind this technetium core is initially demonstrated by using the cold surrogate [Re(CO) 3] (+). NMR studies of the relevant rhenium tricarbonyl complexes indicate the formation of either a monomeric or a possible dimeric complex with each phenolic O atom bridging between two metal centers. Labeling with [ (99m)Tc(CO) 3] (+) provided further insight into the differences in complex formation on the dilute, no carrier added, level compared to the macroscopic scale at which the Re (I) counterparts were made. These new tridentate, monoanionic ligands are competent chelates in binding the [ (99m)Tc(CO) 3] (+) core because radiolabeling yields ranged from 85 to 99% and the resulting complexes were stable to cysteine and histidine challenges for as long as 24 h.     

Influence of the ligand donor atoms on the in vitro stability of rhenium(I) and technetium (I)-99m complexes with pyrazole-containing chelators: Experimental and DFT studies

The new pyrazole-containing ligand 3,5-Me₂pz(CH₂)₂S(CH₂)₂COOH (L¹H) was synthesized and used to prepare the complexes fac-[M(κ³-L¹)(CO)₃] (M = Re (1), ^99mTc(1a)), which were obtained in high yield albeit with a low specific activity in the case of ^99mTc. The X-ray diffraction analysis of 1 confirmed that L¹ coordinates to the metal as monoanionic and through a (N,S,O) donor atom set. Challenge experiments of 1a against cysteine and histidine showed that this complex suffers considerable transchelation in vitro. This contrasts with the behavior exhibited by the related complex fac-[^99mTc(κ³-L²)(CO)₃] (2a) (L² = 3,5-Me₂pz-(CH₂)₂NH-CH₂-COO), anchored by a (N₂O)-tridentate ligand. Biodistribution studies of 1a and 2a in mice indicated that both compounds have a relatively similar biological profile. Nevertheless, the fastest blood clearance and minor hepatic retention found for 2a has shown that this complex is more adequate to be further explored in radiopharmaceutical sciences. DFT calculations (ADF program) were performed for these neutral complexes and related cationic M(I) (M = Re, Tc) tricarbonyl complexes anchored by pyrazole-containing ligands, in order to have a better understanding of the influence of the donor atom set (N,N,O vs. N,O,S; N,N,N vs. N,N,S vs. N,S,S) on their in vitro stability. The differences of the calculated binding energies are not significant, suggesting that the in vitro behavior of these Re(I)/Tc(I) tricarbonyl complexes is not determined by thermodynamic factors.     

Using Tc-Re chemical analogy to synthesize and identify new99mTc complexes

The strong chemical resemblance between Tc and Re is applied to design and evaluate experiments with^99mTc complexes. A combination of spectrophotometric and electrophoretic techniques allows to propose the formula [TcO₂/amine/₂]⁺ for compounds prepared by reduction of^99mTcO ₄ ^– with Zn /solid phase/ in presence of several /bidentate/ amines.     

Rhenium and technetium complexes with tridentate S,N,O ligands derived from benzoylhydrazine

A potentially tridentate ligand with an S,N,O donor set, H₂L, is formed by the reaction of N-[(diethylaminothiocarbonyl)benzimidoyl chloride with benzoylhydrazine. Reactions of H₂L with (NBu₄)[MOCl₄] complexes (M = Re, Tc) give five-coordinate, neutral oxo complexes of the composition [MOCl(L)].Mixed-ligand complexes of rhenium(V) containing the tridentate L^2? ligand and bidentate N,N-dialkyl-N′-benzoylthioureato ligands (R₂btu^?) are formed in high yields when (NBu₄)[ReOCl₄] is treated with mixtures of H₂L and HR₂btu. Another approach to the mixed-ligand products is the reaction of [ReOCl(L)] with an equivalent amount of HR₂btu.     

Comparison of ‘classic’ Tc-DTPA, Tc(CO)3-DTPA and Tc(CO)2(NO)-DTPA

Diethylenetriamine pentaacetic acid (DTPA) was labeled with ^99mTc in three different ways, resulting in ‘classic’ ^99mTc-DTPA, ^99mTc(CO)₃-DTPA and ^99mTc(CO)₂(NO)-DTPA. The biodistribution of the formed DTPA-complexes was studied in mice with a special emphasis on the behavior of the novel tricarbonyl and dicarbonyl-nitrosyl complexes, which was clearly differing from that of ‘classic’ ^99mTc-DTPA. The conversion of a Tc-tricarbonyl complex to a Tc-dicarbonyl-nitrosyl complex using NO⁺ reagents offers a synthetic tool for preparing a novel class of ^99mTc labeled compounds.     

Synthesis of Re(I) complexes bearing tridentate 2,6-bis(7-azaindolyl)phenyl ligand with green emission properties

The Re(I) complexes bearing 2,6-bis(7^′-azaindolyl)phenyl ligand as a tridentate ligand were synthesized by treatment with Re₂(CO)₁₀. The structures of the complexes were confirmed by X-ray crystallography. Both 7-azaindolyl ligands of Re(I) complexes are present in butterfly forms. The Re-C_ipso bonds showed a partial double bond character by π back-donation between the phenyl moiety and Re atom. In THF solution at room temperature, these complexes exhibited green emission (λ_em=510 nm), which is considered to be attributable to MLCT (dz²(Re) →π^* (7^′-azaindolyl group)) transition containing π→π^* (7^′-azaindolyl group) transition.     

Strategic Evaluation of the Traceless Staudinger Ligation for Radiolabeling with the Tricarbonyl Core

The traceless Staudinger ligation with its two variants is a powerful biorthogonal conjugation method not only for the connection of biomolecules, but also for the introduction of fluorescence- or radiolabels under mild reaction conditions. Herein, the strategic evaluation of the traceless Staudinger ligation for radiolabeling ^99mTc using the fac-[Tc(CO)₃]⁺ core is presented. A convenient and high-yielding three-step synthetic procedure of dipicolylamine-based phosphanols as ligands for the mild radiolabeling was developed. The labeling was accomplished using a tricarbonyl kit and a ^99mTc-pertechnetate generator eluate showing 87% radiochemical conversion. The respective rhenium-based, non-radioactive reference compounds were synthesized using (Et₄N)₂[Re(CO)₃Br₃] as precursor. All products were analyzed by NMR, MS, and elemental analysis. Additional XRD analyses were performed.     

Synthesis of pyridyl derivatives for the future functionalization of biomolecules labeled with the fac-[<Superscript>188</Superscript>Re(CO)<Subscript>3</Subscript>(H<Subscript>2</Subscript>O)<Subscript>3</Subscript>]<Superscript>+</Superscript> precursor

In this paper, we investigated three ligand systems, symmetric and asymmetric pyridyl-containing tridentate ligands (L¹NH₂ = (bis(2-pyridylmethyl)-amino)-ethylamine, L²H = (bis(2-pyridylmethyl)-amino)-acetic acid, L³NH₂ = [(6-amino-hexyl)-pyridyl-2-methyl-amino]-acetic acid) as bifunctional chelating agents for labeling biomolecules. These ligands reacted with the precursor fac-[¹⁸⁸Re(CO)₃(H₂O)₃]⁺ and yielded the radioactive complexes fac-[¹⁸⁸Re(CO)₃L] (L = three ligands), which were identified by RP-HPLC. The corresponding stable rhenium tricarbonyl complexes (1–3) were allowed for macroscopic identification of the radiochemical compounds. ¹⁸⁸Re tricarbonyl complexes, with log P _o/w values ranging from −1.36 to −0.32, were obtained with yields of ≥90% using ligand concentrations within the 10⁻⁶−10⁻⁴M range. Challenge studies with cysteine and histidine revealed the high stability properties of these radioactive complexes, and biodistribution studies in normal mice indicated a fast rate of blood clearance and high rate of total radioactivity excretion, primarily through the renal-urinary pathway. In summary, these asymmetric and symmetric pyridyl-containing tridentate ligands are potent bifunctional chelators for the future biomolecules labeling of fac-[¹⁸⁸Re(CO)₃(H₂O)₃]⁺.